{"id":"https://openalex.org/W1963260622","doi":"https://doi.org/10.1111/j.2042-7158.2011.01394.x","title":"Exendin-4 treatment enhances L-DOPA evoked release of striatal dopamine and decreases dyskinetic movements in the 6-hydoxydopamine lesioned rat","display_name":"Exendin-4 treatment enhances L-DOPA evoked release of striatal dopamine and decreases dyskinetic movements in the 6-hydoxydopamine lesioned rat","alternate_titles":[],"publication_year":2012,"publication_date":"2012-05-01","ids":{"openalex":"https://openalex.org/W1963260622","doi":"https://doi.org/10.1111/j.2042-7158.2011.01394.x","mag":"1963260622","pmid":"https://pubmed.ncbi.nlm.nih.gov/22471359"},"language":"en","primary_location":{"id":"doi:10.1111/j.2042-7158.2011.01394.x","doi":"https://doi.org/10.1111/j.2042-7158.2011.01394.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.2042-7158.2011.01394.x","pdf_url":null,"source":{"id":"https://openalex.org/S118304455","display_name":"Journal of Pharmacy and Pharmacology","issn_l":"0022-3573","issn":["0022-3573","2042-7158"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacy and Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1963260622"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5014571817","display_name":"Amjad N. Abuirmeileh","orcid":"https://orcid.org/0000-0002-4480-3038","observed_orcids":["https://orcid.org/0000-0002-4480-3038"]},"institutions":[{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Amjad Abuirmeileh","raw_affiliation_strings":["Department of Pharmacology, The School of Pharmacy, UCL, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, The School of Pharmacy, UCL, UK","institution_ids":["https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079690682","display_name":"Alexander Harkavyi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Alexander Harkavyi","raw_affiliation_strings":["Department of Pharmacology, The School of Pharmacy, UCL, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, The School of Pharmacy, UCL, UK","institution_ids":["https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003725742","display_name":"Nazir Rampersaud","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Nazir Rampersaud","raw_affiliation_strings":["Department of Pharmacology, The School of Pharmacy, UCL, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, The School of Pharmacy, UCL, UK","institution_ids":["https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108848733","display_name":"Rebecca Lever","orcid":"https://orcid.org/0000-0002-5491-2924","observed_orcids":["https://orcid.org/0000-0002-5491-2924"]},"institutions":[{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Rebecca Lever","raw_affiliation_strings":["Department of Pharmacology, The School of Pharmacy, UCL, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, The School of Pharmacy, UCL, UK","institution_ids":["https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085676457","display_name":"John A. Tadross","orcid":"https://orcid.org/0000-0002-8424-1252","observed_orcids":["https://orcid.org/0000-0002-8424-1252"]},"institutions":[{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"John A Tadross","raw_affiliation_strings":["Department of Medicine, Faculty of Medicine, Imperial College London, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Faculty of Medicine, Imperial College London, London, UK","institution_ids":["https://openalex.org/I47508984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011196462","display_name":"Stephen Robert Bloom","orcid":"https://orcid.org/0000-0003-1542-2348","observed_orcids":["https://orcid.org/0000-0003-1542-2348"]},"institutions":[{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Stephen R Bloom","raw_affiliation_strings":["Department of Medicine, Faculty of Medicine, Imperial College London, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Faculty of Medicine, Imperial College London, London, UK","institution_ids":["https://openalex.org/I47508984"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5017380295","display_name":"Peter S. Whitton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Peter S Whitton","raw_affiliation_strings":["Department of Pharmacology, The School of Pharmacy, UCL, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, The School of Pharmacy, UCL, UK","institution_ids":["https://openalex.org/I45129253"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5017380295"],"corresponding_institution_ids":["https://openalex.org/I45129253"],"apc_list":{"value":2911,"currency":"GBP","value_usd":3839},"apc_paid":null,"fwci":0.5532,"has_fulltext":false,"cited_by_count":33,"citation_normalized_percentile":{"value":0.65432851,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"64","issue":"5","first_page":"637","last_page":"643"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10919","display_name":"Deep Brain Stimulation and Movement Disorders","score":0.003599999938160181,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/exendin-4","display_name":"exendin-4","score":1.0},{"id":"https://openalex.org/keywords/glucagon-like-peptide-1-analog","display_name":"glucagon-like peptide-1 analogues","score":0.8180000185966492},{"id":"https://openalex.org/keywords/l-dopa","display_name":"L-DOPA","score":0.9670000076293945},{"id":"https://openalex.org/keywords/lid","display_name":"lid","score":0.5600000023841858},{"id":"https://openalex.org/keywords/dyskinesia","display_name":"dyskinesia","score":0.9110000133514404},{"id":"https://openalex.org/keywords/6-ohda-lesion","display_name":"6-hydroxydopamine lesion","score":0.9309999942779541},{"id":"https://openalex.org/keywords/striatal-dopamine-release","display_name":"striatal dopamine release","score":0.8569999933242798},{"id":"https://openalex.org/keywords/dopamine","display_name":"dopamine","score":0.33799999952316284},{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":0.8980000019073486},{"id":"https://openalex.org/keywords/neuroprotection","display_name":"neuroprotection","score":0.6309999823570251},{"id":"https://openalex.org/keywords/dopaminergic-neurotoxicity","display_name":"dopaminergic neurotoxicity","score":0.6769999861717224}],"concepts":[{"id":"https://openalex.org/C25876315","wikidata":"https://www.wikidata.org/wiki/Q15197465","display_name":"Neurochemical","level":2,"score":0.8616629242897034},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.7943477034568787},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5125699043273926},{"id":"https://openalex.org/C26291073","wikidata":"https://www.wikidata.org/wiki/Q310484","display_name":"Ex vivo","level":3,"score":0.48787927627563477},{"id":"https://openalex.org/C2779734285","wikidata":"https://www.wikidata.org/wiki/Q11085","display_name":"Parkinson's disease","level":3,"score":0.48425599932670593},{"id":"https://openalex.org/C2779026782","wikidata":"https://www.wikidata.org/wiki/Q818165","display_name":"Benserazide","level":5,"score":0.47669717669487},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4262581467628479},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.394757479429245},{"id":"https://openalex.org/C2780304432","wikidata":"https://www.wikidata.org/wiki/Q300989","display_name":"Levodopa","level":4,"score":0.3686593770980835},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3630228042602539},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3198709487915039},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.07034015655517578},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.0},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000077270","descriptor_name":"Exenatide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001522","descriptor_name":"Behavior, Animal","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003342","descriptor_name":"Corpus Striatum","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D003342","descriptor_name":"Corpus Striatum","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003342","descriptor_name":"Corpus Striatum","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D004298","descriptor_name":"Dopamine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007980","descriptor_name":"Levodopa","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D007980","descriptor_name":"Levodopa","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007980","descriptor_name":"Levodopa","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008116","descriptor_name":"Lizards","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014688","descriptor_name":"Venoms","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014688","descriptor_name":"Venoms","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016627","descriptor_name":"Oxidopamine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017208","descriptor_name":"Rats, Wistar","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020734","descriptor_name":"Parkinsonian Disorders","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D020734","descriptor_name":"Parkinsonian Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D020734","descriptor_name":"Parkinsonian Disorders","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D020820","descriptor_name":"Dyskinesias","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D020820","descriptor_name":"Dyskinesias","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D020820","descriptor_name":"Dyskinesias","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1111/j.2042-7158.2011.01394.x","doi":"https://doi.org/10.1111/j.2042-7158.2011.01394.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.2042-7158.2011.01394.x","pdf_url":null,"source":{"id":"https://openalex.org/S118304455","display_name":"Journal of Pharmacy and Pharmacology","issn_l":"0022-3573","issn":["0022-3573","2042-7158"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacy and Pharmacology","raw_type":"journal-article"},{"id":"pmid:22471359","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22471359","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of pharmacy and pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:eprints.ucl.ac.uk.OAI2:1350423","doi":null,"is_oa":false,"landing_page_url":"http://discovery.ucl.ac.uk/1350423/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400024","display_name":"UCL Discovery (University College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I45129253","host_organization_name":"University College London","host_organization_lineage":["https://openalex.org/I45129253"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"JOURNAL OF PHARMACY AND PHARMACOLOGY , 64 (5) pp. 637-643. (2012)","raw_type":"Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9907000064849854}],"study_designs":[],"awards":[{"id":"https://openalex.org/G559850962","display_name":"Centre for Integrative Physiology and Pharmacology at Imperial","funder_award_id":"BB/E52708X/1","funder_id":"https://openalex.org/F4320334629","funder_display_name":"Biotechnology and Biological Sciences Research Council"}],"funders":[{"id":"https://openalex.org/F4320334629","display_name":"Biotechnology and Biological Sciences Research Council","ror":"https://ror.org/00cwqg982"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":28,"referenced_works":["https://openalex.org/W249845531","https://openalex.org/W1511761223","https://openalex.org/W1524119775","https://openalex.org/W1558522787","https://openalex.org/W1718365317","https://openalex.org/W1970416276","https://openalex.org/W1977346153","https://openalex.org/W1981170797","https://openalex.org/W1995565667","https://openalex.org/W1996001296","https://openalex.org/W1998818358","https://openalex.org/W1999529189","https://openalex.org/W2004644468","https://openalex.org/W2006568691","https://openalex.org/W2011305790","https://openalex.org/W2011655032","https://openalex.org/W2045846363","https://openalex.org/W2057410639","https://openalex.org/W2071948878","https://openalex.org/W2080785707","https://openalex.org/W2102071852","https://openalex.org/W2106631077","https://openalex.org/W2125300721","https://openalex.org/W2129969030","https://openalex.org/W2141311399","https://openalex.org/W2146061719","https://openalex.org/W2150857721","https://openalex.org/W2163815564"],"related_works":["https://openalex.org/W2048311111","https://openalex.org/W3048449568","https://openalex.org/W2007689851","https://openalex.org/W3115238694","https://openalex.org/W2047101630","https://openalex.org/W2856796550","https://openalex.org/W2410459817","https://openalex.org/W2115613566","https://openalex.org/W4399422401","https://openalex.org/W1515339308"],"abstract_inverted_index":{"OBJECTIVES:":[0],"To":[1,66],"determine":[2,63],"whether":[3,21],"the":[4,12,125,144,160,176],"glucagon-like":[5],"1":[6],"peptide":[7],"analogue":[8],"exendin-4":[9],"(EX-4)":[10],"augments":[11],"neurochemical":[13,92],"effects":[14,102,126],"of":[15,103,127,131,162,173],"a":[16,116,128],"single":[17,129],"L-DOPA":[18,25,51,71,104,138,163,174],"treatment":[19,123],"and":[20,36,52,88,167],"EX-4":[22,41,69,96,108,114,122,157],"can":[23],"decrease":[24],"induced":[26,99],"dyskinesias":[27],"(LIDS).":[28],"METHODS:":[29],"Rats":[30],"were":[31,49,59,72,80,105],"lesioned":[32,110],"with":[33,113,156,164],"6-hydroxydopamine":[34],"(6-OHDA)":[35],"7":[37,43,75],"days":[38,76],"later":[39],"given":[40,50],"for":[42],"days.":[44],"The":[45,57,149],"following":[46],"day,":[47],"rats":[48],"extracellular":[53],"dopamine":[54],"was":[55],"measured.":[56],"animals":[58],"then":[60],"killed":[61],"to":[62,91,143],"tissue":[64],"dopamine.":[65],"study":[67],"LIDS,":[68],"and/or":[70],"co-administered":[73],"daily,":[74],"after":[77],"6-OHDA.":[78],"LIDS":[79,152],"determined":[81],"on":[82],"Days":[83],"2,":[84],"4,":[85],"8,":[86],"12":[87],"16":[89],"prior":[90],"assessment.":[93],"KEY":[94],"FINDINGS:":[95],"reduced":[97],"6-OHDA":[98],"damage.":[100],"Acute":[101],"potentiated":[106],"by":[107],"in":[109,119,147,151,175],"rats.":[111],"Treatments":[112],"caused":[115],"progressive":[117],"reduction":[118,150],"LIDS.":[120],"CONCLUSIONS:":[121],"potentiates":[124],"dose":[130],"L-DOPA.":[132],"This":[133],"augmentation":[134],"indicates":[135],"that":[136,154],"lower":[137],"doses":[139],"might":[140],"be":[141],"used":[142],"same":[145],"effect":[146],"patients.":[148],"suggests":[153],"co-treatment":[155],"could":[158],"allow":[159,170],"use":[161],"fewer":[165],"side-effects":[166],"possibly":[168],"therefore":[169],"earlier":[171],"introduction":[172],"clinic.":[177]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1963260622","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":2}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
